NCT03185039 2026-03-19
Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic Agents
Institut Paoli-Calmettes
Phase NA Active not recruiting
Institut Paoli-Calmettes
Institut du Cancer de Montpellier - Val d'Aurelle
University Hospital, Clermont-Ferrand
Centre Hospitalier Universitaire de Besancon
Hospices Civils de Lyon